{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:22:51Z","timestamp":1793254971070,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["DP006302"],"award-info":[{"award-number":["DP006302"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Program of Cancer Registries","award":["NU58DP006347-01"],"award-info":[{"award-number":["NU58DP006347-01"]}]},{"name":"National Program of Cancer Registries","award":["5U58DP003875-01"],"award-info":[{"award-number":["5U58DP003875-01"]}]},{"name":"National Program of Cancer Registries","award":["NU58DP007161"],"award-info":[{"award-number":["NU58DP007161"]}]},{"name":"National Program of Cancer Registries","award":["NU58DP006332-03-00"],"award-info":[{"award-number":["NU58DP006332-03-00"]}]},{"name":"National Program of Cancer Registries","award":["NU58DP007114"],"award-info":[{"award-number":["NU58DP007114"]}]},{"name":"National Program of Cancer Registries","award":["NU58DP006271-04-00"],"award-info":[{"award-number":["NU58DP006271-04-00"]}]},{"name":"National Program of Cancer Registries","award":["17NU58DP006334"],"award-info":[{"award-number":["17NU58DP006334"]}]},{"name":"National Program of Cancer Registries","award":["NU58DP007117"],"award-info":[{"award-number":["NU58DP007117"]}]},{"name":"National Program of Cancer Registries","award":["6NU58\/DP006309"],"award-info":[{"award-number":["6NU58\/DP006309"]}]},{"name":"National Program of Cancer Registries","award":["1NU58DP006281"],"award-info":[{"award-number":["1NU58DP006281"]}]},{"name":"National Program of Cancer Registries","award":["1NU58DP0063085NU58DP006308-04-00"],"award-info":[{"award-number":["1NU58DP0063085NU58DP006308-04-00"]}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201300019I"],"award-info":[{"award-number":["HHSN261201300019I"]}],"id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201800007I"],"award-info":[{"award-number":["HHSN261201800007I"]}],"id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN26100002"],"award-info":[{"award-number":["HHSN26100002"]}],"id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201800008l"],"award-info":[{"award-number":["HHSN261201800008l"]}],"id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["75N91021D00009"],"award-info":[{"award-number":["75N91021D00009"]}],"id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201800009I"],"award-info":[{"award-number":["HHSN261201800009I"]}],"id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007558","name":"Rutgers Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017027","name":"State of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Maryland Cigarette Restitution Fund"},{"name":"Louisiana Tumor Registry","award":["0587200015"],"award-info":[{"award-number":["0587200015"]}]},{"name":"New York State Cancer Registry"},{"name":"National HIV Surveillance Systems","award":["NU62PS003960"],"award-info":[{"award-number":["NU62PS003960"]}]},{"name":"National HIV Surveillance Systems","award":["5U62PS001005-05"],"award-info":[{"award-number":["5U62PS001005-05"]}]},{"name":"National HIV Surveillance Systems","award":["NU62PS924532"],"award-info":[{"award-number":["NU62PS924532"]}]},{"name":"National HIV Surveillance Systems","award":["NU62PS924522-02-00"],"award-info":[{"award-number":["NU62PS924522-02-00"]}]},{"name":"National HIV Surveillance Systems","award":["U62PS004011-02"],"award-info":[{"award-number":["U62PS004011-02"]}]},{"name":"National HIV Surveillance Systems","award":["U62PS004001-2"],"award-info":[{"award-number":["U62PS004001-2"]}]},{"name":"National HIV Surveillance Systems","award":["NU62PS924546-02-00"],"award-info":[{"award-number":["NU62PS924546-02-00"]}]},{"name":"National HIV Surveillance Systems","award":["PS18-1802"],"award-info":[{"award-number":["PS18-1802"]}]},{"DOI":"10.13039\/100005258","name":"National Center for HIV, Viral Hepatitis, STD, and TB Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with human immunodeficiency virus (HIV, PWH) and cancer have greater cancer-specific mortality than patients without HIV, which may reflect effects of immunosuppression. We aimed to describe the associations between low CD4-cell counts and cancer-specific mortality in PWH with cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used linked data from HIV and cancer registries to study 12 common cancers in PWH in 14 registries in the United States and Puerto Rico in 2008\u20132019. We used Cox regression to estimate hazard ratios (HRs) for the association of CD4 counts measured after cancer diagnosis (0\u201349, 50\u201399, 100\u2013199, and 200+ CD4 cells\/mm3) with cancer-specific mortality, adjusted for demographic and cancer-related factors. We estimated 3-year cancer-specific cumulative mortality using Fine\u2013Gray models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We evaluated 12 087 PWH and cancer (the most common being non-Hodgkin lymphoma [NHL, N = 2311], prostate cancer [N = 1681], and Kaposi sarcoma [KS, N = 1423]). Cancer-specific mortality was significantly greater for individuals with a CD4 count of 0\u201349 compared with 200+ cells\/mm3 for NHL (HR = 1.82, 95% CI = 1.30\u20132.53), prostate cancer (HR = 3.98, 95% CI = 1.56\u201310.15), KS (HR = 4.16, 95% CI = 1.49\u201311.67), lung cancer (HR = 1.69, 95% CI = 1.33\u20132.14), colorectal cancer (HR = 2.79, 95% CI = 1.58\u20134.92), and liver cancer (HR = 1.44, 95% CI = 1.01\u20132.70). For lung cancer, those with a CD4 count of 200+ cells\/mm3 had 3-year cancer-specific cumulative mortality of 52% versus 72% for those with a CD4 count of 0\u201349.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among PWH with cancer, cancer-specific mortality increased with lower CD4 counts, including for solid tumors not associated with HIV, eg, prostate and lung cancer. These results highlight the role of immunity in control of cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag333","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:39:48Z","timestamp":1779968388000},"page":"e795-e803","source":"Crossref","is-referenced-by-count":0,"title":["Markers of Immune Function and Survival Among Cancer Patients With HIV in the United States: A Population-based Registry Linkage Study"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8211-0806","authenticated-orcid":false,"given":"Cameron B","family":"Haas","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith S","family":"Shiels","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9390-9448","authenticated-orcid":false,"given":"Qianlai","family":"Luo","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-2698","authenticated-orcid":false,"given":"Ruth M","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5933-211X","authenticated-orcid":false,"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[{"name":"University of Utah Spencer Fox Eccles School of Medicine Department of Radiation Oncology, , Salt Lake City, Utah ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-6957","authenticated-orcid":false,"given":"Analise","family":"Monterosso","sequence":"additional","affiliation":[{"name":"Texas Department of State Health Services, HIV Surveillance Registry , Austin, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2693-2701","authenticated-orcid":false,"given":"Kate","family":"Drezner","sequence":"additional","affiliation":[{"name":"HIV\/AIDS, Hepatitis, STD and TB Administration, District of Columbia Department of Health, Washington, District of Columbia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittani","family":"Saafir","sequence":"additional","affiliation":[{"name":"HIV\/AIDS, Hepatitis, STD and TB Administration, District of Columbia Department of Health, Washington, District of Columbia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3993-0174","authenticated-orcid":false,"given":"Jennifer","family":"Hayes","sequence":"additional","affiliation":[{"name":"Maryland Cancer Registry , Maryland Department of Health, Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A","family":"Engels","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2026102813511324100_ciag333-B1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/QAI.0b013e3181f53783","article-title":"Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users","volume":"55","author":"Shiels","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026102813511324100_ciag333-B2","doi-asserted-by":"crossref","first-page":"e2200330","DOI":"10.1200\/GO.22.00330","article-title":"Survival disparities between patients with breast cancer with and without HIV: a research framework","volume":"9","author":"Chasimpha","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"2026102813511324100_ciag333-B3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/QAD.0000000000000690","article-title":"Lung cancer incidence and survival among HIV-infected and uninfected women and men","volume":"29","author":"Hessol","year":"2015","journal-title":"AIDS (London, England)"},{"key":"2026102813511324100_ciag333-B4","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/j.cllc.2020.11.006","article-title":"Decreased overall survival in HIV-associated non\u2013small-cell lung cancer","volume":"22","author":"Hysell","year":"2021","journal-title":"Clinical Lung Cancer"},{"key":"2026102813511324100_ciag333-B5","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Lancet HIV"},{"key":"2026102813511324100_ciag333-B6","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026102813511324100_ciag333-B7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1158\/1055-9965.EPI-16-0964","article-title":"Excess mortality among HIV-infected individuals with cancer in the United States","volume":"26","author":"Coghill","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026102813511324100_ciag333-B8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaoncol.2019.4648","article-title":"Immune status and associated mortality after cancer treatment among individuals with HIV in the antiretroviral therapy era","volume":"6","author":"Calkins","year":"2020","journal-title":"JAMA Oncol"},{"key":"2026102813511324100_ciag333-B9","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/cncr.32158","article-title":"Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the national cancer data base","volume":"125","author":"Coghill","year":"2019","journal-title":"Cancer"},{"key":"2026102813511324100_ciag333-B10","doi-asserted-by":"crossref","first-page":"e191742","DOI":"10.1001\/jamaoncol.2019.1742","article-title":"HIV infection, cancer treatment regimens, and cancer outcomes among elderly adults in the United States","volume":"5","author":"Coghill","year":"2019","journal-title":"JAMA Oncol"},{"key":"2026102813511324100_ciag333-B11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/COH.0000000000000320","article-title":"Cancer care disparities in people with HIV in the United States","volume":"12","author":"Suneja","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"2026102813511324100_ciag333-B12","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"Suneja","year":"2014","journal-title":"J Clin Oncol"},{"key":"2026102813511324100_ciag333-B13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAD.0b013e32835ad56e","article-title":"Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals","volume":"27","author":"Suneja","year":"2013","journal-title":"AIDS"},{"key":"2026102813511324100_ciag333-B14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cncr.31782","article-title":"Survival after a cancer diagnosis among solid organ transplant recipients in the United States","volume":"125","author":"D'Arcy","year":"2019","journal-title":"Cancer"},{"key":"2026102813511324100_ciag333-B15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-131-4-199908170-00004","article-title":"Plasma HIV viral load in patients with hemophilia and late-stage HIV disease: a measure of current immune suppression. Multicenter hemophilia cohort study","volume":"131","author":"Engels","year":"1999","journal-title":"Ann Intern Med"},{"key":"2026102813511324100_ciag333-B16","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1111\/ajt.15495","article-title":"Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer","volume":"19","author":"Engels","year":"2019","journal-title":"Am J Transplant"},{"key":"2026102813511324100_ciag333-B17","doi-asserted-by":"crossref","first-page":"972021","DOI":"10.3389\/fimmu.2022.972021","article-title":"Roles of CD4+ T cells as mediators of antitumor immunity","volume":"13","author":"Kravtsov","year":"2022","journal-title":"Front Immunol"},{"key":"2026102813511324100_ciag333-B18","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.3390\/cancers15153972","article-title":"Innate immune system in the context of radiation therapy for cancer","volume":"15","author":"Boopathi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026102813511324100_ciag333-B19","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/jnci\/djq366","article-title":"Improved estimates of cancer-specific survival rates from population-based data","volume":"102","author":"Howlader","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"2026102813511324100_ciag333-B20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10985-008-9099-8","article-title":"Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data","volume":"14","author":"van Houwelingen","year":"2008","journal-title":"Lifetime Data Anal"},{"key":"2026102813511324100_ciag333-B21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2026102813511324100_ciag333-B22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/01621459.1974.10480146","article-title":"Nonparametric estimation of a survivorship function with doubly censored data","volume":"69","author":"Turnbull","year":"1974","journal-title":"J Am Stat Assoc"},{"key":"2026102813511324100_ciag333-B23","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1093\/cid\/ciaa1016","article-title":"Deaths attributable to cancer in the US human immunodeficiency virus population during 2001-2015","volume":"72","author":"Horner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026102813511324100_ciag333-B24","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/ijc.32895","article-title":"Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort studies","volume":"146","author":"Trickey","year":"2020","journal-title":"Int J Cancer"},{"key":"2026102813511324100_ciag333-B25","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1158\/1055-9965.EPI-24-0478","article-title":"Excess mortality in persons with concurrent HIV and cancer diagnoses: a retrospective cohort study","volume":"33","author":"Lee","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026102813511324100_ciag333-B26","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with medicare claims","volume":"54","author":"Noone","year":"2016","journal-title":"Medical Care"},{"key":"2026102813511324100_ciag333-B27","doi-asserted-by":"crossref","first-page":"e7195","DOI":"10.1002\/cam4.7195","article-title":"Expression and prognostic significance of the PD-1\/PD-L1 pathway in AIDS-related non-Hodgkin lymphoma","volume":"13","author":"Zhao","year":"2024","journal-title":"Cancer Med"},{"key":"2026102813511324100_ciag333-B28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4(+) T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"key":"2026102813511324100_ciag333-B29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026102813511324100_ciag333-B30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.6004\/jnccn.2018.0066","article-title":"Cancer in people living with HIV, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Reid","year":"2018","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag333\/68433617\/ciag333.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/4\/e795\/68433617\/ciag333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/4\/e795\/68433617\/ciag333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:51:22Z","timestamp":1793209882000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/4\/e795\/8698223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,29]]},"published-print":{"date-parts":[[2026,10,28]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag333","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,5,29]]}}}